Cargando…
Comparison of Efficacy of Anti-interleukin-17 in the Treatment of Psoriasis Between Caucasians and Asians: A Systematic Review and Meta-Analysis
BACKGROUND: Interleukin-17 (IL-17) monoclonal antibody drugs have been increasingly significant in the treatment of psoriasis, but it is not clear whether the efficacy is equivalent across ethnicities. OBJECTIVE: To explore the differences of short-term efficacy of IL-17 inhibitors between Caucasian...
Autores principales: | Zhang, Danyi, Qiu, Jianing, Liao, Xing, Xiao, Yi, Shen, Minxue, Deng, Yaxiong, Jing, Danrong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822240/ https://www.ncbi.nlm.nih.gov/pubmed/35145980 http://dx.doi.org/10.3389/fmed.2021.814938 |
Ejemplares similares
-
Association of Psoriasis With Anxiety and Depression: A Case–Control Study in Chinese Patients
por: Jing, Danrong, et al.
Publicado: (2021) -
Risk of Herpes Zoster Among Psoriasis Patients Taking Biologics: A Network Meta-Analysis of Cohort Studies
por: Tang, Zhenwei, et al.
Publicado: (2021) -
Targeting of interleukin-17 in the treatment of psoriasis
por: Lønnberg, Ann Sophie, et al.
Publicado: (2014) -
Interleukin-17A and Keratinocytes in Psoriasis
por: Furue, Masutaka, et al.
Publicado: (2020) -
Effectiveness and Safety of Anti-interleukin-17 Therapies in Elderly Patients with Psoriasis
por: PHAN, Céline, et al.
Publicado: (2020)